African Swine Fever Drug may be useful in treating autism and raises hopes for Chronic Fatigue Syndrome patients.
Background on Suramin as a treatment of African Swine Fever (which may actually be HHV-6, HHV-7 and HHV-8 in humans)
Actinobolin, atropine, carrageenan, megalomycin C, suramin, and tetracenomycin C were tested for their activity against African swine fever virus replication. Both viral inhibitory potency and cytotoxicity were investigated. Megalomycin C, suramin, atropine, and carrageenan exhibited significant activity. Megalomycin C was the most active of the four agents with respect to the concentration of compound that blocked the formation of infectious virus by 50%. Suramin was the next most active agent in this respect, but because of its lower cytotoxicity, it had the most favorable therapeutic index.
Suramin is showing promise in the treatment of autism and may be tried for Chronic Fatigue Syndrome.
Is it because HHV-6 and related viruses are potential triggers of autism and CFS and the virus is allegedly a form of African Swine Fever that was renamed by Robert Gallo after he stole credit for the discovery of African Swine Fever in AIDS patients by John Beldekas and Jane Teas? (See Beldekas/Teas story here.)
New agents active against African swine fever virus.
Abstract
Parent Personal Statements of Their Observations from Phase I/II Randomized Clinical Trial of Low-Dose Suramin in Autism Spectrum Disorder